Scientific rationale for the inclusion and exclusion criteria for intravenous alteplase in acute ischemic stroke: a statement for healthcare professionals from the …
BM Demaerschalk, DO Kleindorfer, OM Adeoye… - Stroke, 2016 - Am Heart Assoc
Purpose—To critically review and evaluate the science behind individual eligibility criteria
(indication/inclusion and contraindications/exclusion criteria) for intravenous recombinant …
(indication/inclusion and contraindications/exclusion criteria) for intravenous recombinant …
Absolute and relative contraindications to IV rt-PA for acute ischemic stroke
JE Fugate, AA Rabinstein - The Neurohospitalist, 2015 - journals.sagepub.com
Most of the contraindications to the administration of intravenous (IV) recombinant tissue
plasminogen activator (rtPA) originated as exclusion criteria in major stroke trials. These …
plasminogen activator (rtPA) originated as exclusion criteria in major stroke trials. These …
Thrombectomy for primary distal posterior cerebral artery occlusion stroke: the TOPMOST study
L Meyer, CP Stracke, N Jungi, M Wallocha… - JAMA …, 2021 - jamanetwork.com
Importance Clinical evidence of the potential treatment benefit of mechanical thrombectomy
for posterior circulation distal, medium vessel occlusion (DMVO) is sparse. Objective To …
for posterior circulation distal, medium vessel occlusion (DMVO) is sparse. Objective To …
Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American …
Background and Purpose—The authors present an overview of the current evidence and
management recommendations for evaluation and treatment of adults with acute ischemic …
management recommendations for evaluation and treatment of adults with acute ischemic …
Why are acute ischemic stroke patients not receiving IV tPA? Results from a national registry
Objective: To determine patient and hospital characteristics associated with not providing IV
tissue plasminogen activator (tPA) to eligible patients with acute ischemic stroke (AIS) in …
tissue plasminogen activator (tPA) to eligible patients with acute ischemic stroke (AIS) in …
Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at get with the guidelines–stroke …
LH Schwamm, SF Ali, MJ Reeves… - … Quality and Outcomes, 2013 - Am Heart Assoc
Background—Substantial efforts over the past decade have increased rates of intravenous
tissue plasminogen activator (tPA) use in the United States. We sought to determine …
tissue plasminogen activator (tPA) use in the United States. We sought to determine …
Baseline NIH Stroke Scale Score predicting outcome in anterior and posterior circulation strokes
S Sato, K Toyoda, T Uehara, N Toratani, C Yokota… - Neurology, 2008 - AAN Enterprises
Objective: The NIH Stroke Scale (NIHSS) may not appropriately assess the spectrum of
posterior circulation (PC)–related neurologic deficits. We determined the cutoff baseline …
posterior circulation (PC)–related neurologic deficits. We determined the cutoff baseline …
Outcomes in mild or rapidly improving stroke not treated with intravenous recombinant tissue-type plasminogen activator: findings from Get With The Guidelines …
Background and Purpose—Mild or rapidly improving stroke is a frequently cited reason for
not giving intravenous recombinant tissue-type plasminogen activator (rtPA), but some of …
not giving intravenous recombinant tissue-type plasminogen activator (rtPA), but some of …
The impact of mild stroke on meaningful activity and life satisfaction
DF Edwards, M Hahn, C Baum… - Journal of stroke and …, 2006 - Elsevier
Patients with mild stroke are assumed to achieve full recovery with little or no intervention.
However, recent studies suggest that such patients may experience persistent disability and …
However, recent studies suggest that such patients may experience persistent disability and …
Outcomes in mild acute ischemic stroke treated with intravenous thrombolysis: a retrospective analysis of the Get With the Guidelines–Stroke registry
Importance Mild strokes have been poorly represented in thrombolytic trials and only a few
series have reported outcomes after treatment with intravenous (IV) recombinant tissue …
series have reported outcomes after treatment with intravenous (IV) recombinant tissue …